Elanco Animal Health Incorporated
ELAN
Classifica tra le azioni
#1817
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces,... Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Prezzo delle azioni
$23.54
Ultima sincronizzazione: 2026-10-16
Capitalizzazione di mercato
$11.76B
Variazione (1 giorno)
0.17%
Variazione (1 anno)
9.90%
Paese
US
Scambia Elanco Animal Health Incorporated (ELAN)
Categoria
Healthcare
Margine operativo per Elanco Animal Health Incorporated (ELAN)
Margine operativo al October 2026 TTM: 9.20%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Elanco Animal Health Incorporated, il margine operativo attuale (TTM) è 9.20%. Alla fine del 2023, il margine operativo era 7.38%.
Storico del margine operativo per Elanco Animal Health Incorporated da 2015 a 2026
Margine operativo alla fine di ogni anno
| Anno | Margine Operativo | Cambia |
|---|---|---|
| 2026 (TTM) | 9.20% | 62.83% |
| 2024 | 5.65% | -23.44% |
| 2023 | 7.38% | -15.27% |
| 2022 | 8.71% | 36.52% |
| 2021 | 6.38% | -371.49% |
| 2020 | -2.35% | -119.50% |
| 2019 | 12.05% | 17.79% |
| 2018 | 10.23% | 107.51% |
| 2017 | 4.93% | -49.28% |
| 2016 | 9.72% | 5,015.79% |
| 2015 | 0.19% | 0.00% |
Margine operativo per aziende simili o concorrenti
| Azienda | Margine Operativo | Differenza del margine operativo | Il paese |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -97.51% |
IN
|
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.